Kent State University, located in Kent, Ohio, is a prominent public doctoral university established in 1910, recognized for its high research activity. As the highest-ranking public university in Northern Ohio, it offers a diverse array of academic programs, including undergraduate majors in fields such as Biomedical Sciences, Communication Studies, Psychology, and Visual Communication and Design. Students have access to over 300 academic programs across Kent State's eight campuses and can participate in more than 200 student organizations, fostering a vibrant campus life. The university provides various financial aid options, including need-based awards and graduate assistantships, to support students in their educational pursuits. Admissions for freshmen require a minimum GPA and standardized test scores, though alternative pathways exist for those who do not meet these criteria. Kent State University plays a vital role in the educational landscape of Ohio, contributing to the development of its students through comprehensive academic and extracurricular offerings.
Director, Technology Commercialization and Research Finance
2 past transactions
RXQ Compounding
Series A in 2018
RXQ Compounding, LLC is an FDA-approved 503B Outsourcing Facility located in Athens, Ohio, specializing in the manufacture and distribution of sterile and non-sterile medications throughout the United States. Founded in 2014, the company offers a diverse range of products including sterile and non-sterile injectables, veterinary medications, dermatologic creams and ointments, ophthalmic solutions, and orthopedic steroids, along with custom production solutions for hospitals. RXQ Compounding emphasizes safety and quality by adhering to rigorous regulatory standards and has developed a proprietary procedural manual to ensure compliance with FDA guidelines. The company's commitment to delivering reliable compounded drugs enables healthcare providers to access quality medications efficiently, ultimately supporting optimal patient outcomes.
Remesh
Seed Round in 2014
Remesh Inc. operates an AI-powered platform that facilitates live conversations with customers or employees, allowing users to engage with up to 1,000 participants simultaneously. Founded in 2013 and based in the United States, the company focuses on gathering and analyzing audience responses in real-time. This technology enables organizations to quickly collect valuable insights and opinions, empowering them to make more informed business decisions. By integrating artificial intelligence with market research, Remesh provides a unique solution for advertisers and brands to understand the collective thinking of their target audiences, thus enhancing their ability to communicate effectively and respond to consumer needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.